ENTRY       D11262                      Drug
NAME        Andecaliximab (USAN/INN)
FORMULA     C6396H9868N1680O2010S46
EXACT_MASS  143842.8754
MOL_WEIGHT  143931.8291
SEQUENCE    (Heavy chain)
            XVQLQESGPG LVKPSETLSL TCTVSGFSLL SYGVHWVRQP PGKGLEWLGV IWTGGTTNYN
            SALMSRFTIS KDDSKNTVYL KMNSLKTEDT AIYYCARYYY GMDYWGQGTL VTVSSASTKG
            PSVFPLAPCS RSTSESTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL
            SSVVTVPSSS LGTKTYTCNV DHKPSNTKVD KRVESKYGPP CPPCPAPEFL GGPSVFLFPP
            KPKDTLMISR TPEVTCVVVD VSQEDPEVQF NWYVDGVEVH NAKTKPREEQ FNSTYRVVSV
            LTVLHQDWLN GKEYKCKVSN KGLPSSIEKT ISKAKGQPRE PQVYTLPPSQ EEMTKNQVSL
            TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSRLTVDKS RWQEGNVFSC
            SVMHEALHNH YTQKSLSLSL G
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCKASQDVR NTVAWYQQKP GKAPKLLIYS SSYRNTGVPD
            RFSGSGSGTD FTLTISSLQA EDVAVYYCQQ HYITPYTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H95, H129-L214, H142-H198, H221-H'221, H224-H'224, H256-H316, H362-H420, H'22-H'95, H'129-L'214, H'142-H'198, H'256-H'316, H'362-H'420, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Anti-inflammatory, Antineoplastic, Anti-matrix metalloproteinase 9 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of cancer and inflammatory diseases
TARGET      MMP9 [HSA:4318] [KO:K01403]
  PATHWAY   hsa01522(4318)  Endocrine resistance
BRITE       Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Metallo peptidases
                MMP9
                 D11262  Andecaliximab (USAN/INN)
DBLINKS     CAS: 1518996-49-0
            PubChem: 384585240
///
